Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in Severe COPD Exacerbation
NCT01353235Phase 3Completed
- Start
- Apr 2010
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisolone in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: ICU mortality rate. Started Apr 2010; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01353235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01353235.